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Abstract
Background: CCN-proteins are known to be involved in development, homeostasis and repair
of mesenchymal tissues. Since these processes implicate recruitment of cells with the potential to
be committed to various phenotypes, we studied the effect of CYR61/CCN1 and WISP3/CCN6
on migration of human bone marrow derived mesenchymal stroma cells (MSCs) in comparison to
in vitro osteogenic differentiated MSCs using a modified Boyden chamber assay.
Results: CYR61 and WISP3 were purified as fusion proteins with a C-terminal Fc-tag from
baculovirus infected SF21 cells using protein G sepharose columns. CYR61 and WISP3 stimulated
cell migration of undifferentiated MSCs in a dose-dependent manner. CYR61 and WISP3 had similar
effects on committed osteogenic precursor cells. Checkerboard analysis revealed that CYR61 and
WISP3 stimulated true directed cell migration (chemotaxis) of MSCs and committed osteogenic
precursors. In MSCs the chemotactic activity of WISP3 but not CYR61 was mediated through
integrin ανß5.
Conclusion: Our results indicate that CYR61 and WISP3 can function as soluble ligands
transmitting chemotactic signals to human MSCs but differ in the involvement of integrin ανß5. This
may be relevant for their possible role in connective tissue repair.
Background
Members of the cysteine-rich 61/connective tissue growth
factor/nephroblastoma overexpressed (CCN1-3) family
of genes (CCN-family) have been reported to be involved
in central cell-biological processes such as cell adhesion,
migration, proliferation, differentiation and survival [1-
3]. Additional CCN proteins are the wnt induced secreted
proteins WISP1/CCN4, WISP2/CCN5 and WISP3/CCN6.
The CCN proteins share a common modular structure
comprising an insulin-like growth factor binding motif, a
von Willebrand type C domain and a thrombospondin
type I domain [3]. Based on the identical position of con-
served cysteine residues within these proteins they are
considered a structural family, but vary in function.
CYR61 is considered as an angiogenic inducer, which
binds to integrin receptors and proteoglycans [2,3].
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Various CCN-proteins have been implicated in chondro-
genesis and bone formation as well as angiogenesis dur-
ing development and adult life [2]. These biological
processes are also essential for skeletal tissue regeneration
involving both endothelial and mesenchymal progenitor
cells. Local recruitment of cells with the capacity to differ-
entiate along the osteoblastic lineage for example is neces-
sary for bone growth, remodeling and repair. The
underlying cell-biological processes involve multipotent
mesenchymal progenitor cells, which have been identi-
fied in bone marrow and various skeletal tissues including
bone and cartilage [4-6]. Therefore, mechanisms regulat-
ing directed migration of undifferentiated cells might play
an important role in skeletal physiology and pathology.
Different chemokine receptors including CXCR4, CCR7,
CCR1 and CX3CR1 have been identified on MSCs and
stromal-derived factor (SDF)-1 has been shown to possess
chemotactic activitiy for CXCR4-positive MSCs [7-9]. Fur-
ther candidates for mediating chemotactic signals to bone
marrow derived MSCs are growth factors, which are
released during tissue remodeling or fracture healing.
Thus it is not surprising that a chemotactic response of
human bone marrow derived mesenchymal progenitor
cells to factors like bone morphogenetic protein-2 (BMP-
2), platelet-derived growth factor-isoforms (PDGF-AA,
AB, BB), basic fibroblast growth factor (bFGF) or IGF-I
and -II, has been demonstrated [10-14]. Some of these
factors exhibited preferential or exclusive activity in oste-
oblastic cells while others showed enhanced activity in
MSCs [13,15]. Vascular endothelial growth factor-A
(VEGF-A), which has been shown to act as a coupling fac-
tor for angiogenesis and bone formation, stimulated
directed cell migration of endothelial cells mainly via
VEGFR2 and that of MSCs via VEGFR1 [15,16]. A dual
function on bone formation and vascularisation has also
been attributed to CYR61/CCN1 [17]. Recently, overex-
pression of CYR61/CCN1 has been identified as a chemo-
tactic stimulus for the mesenchymal stem cell line
C3H10T1/2 [18].
The observation that mutations in WISP3/CCN6 lead to
progressive pseudorheumatoid dysplasia (PPRD) and
polyarticular juvenile idiopathic arthritis, diseases that are
associated with cartilage growth plate defects and/or loss
of adult articular cartilage indicates that this CCN-protein
might be related to the preservation of cartilage integrity
[19,20]. It has been shown that WISP3/CCN6 stimulates
collagen type II, aggrecan as well as superoxide dismutase
expression and activity in chondrocytes [21,22]. Potential
effects on mesenchymal stem cells, however, have not
been described so far, although a differential expression of
CCN-family members in human MSCs during osteogenic,
chondrogenic or adipogenic differentiation has been
reported. Both CYR61 and WISP3 were found to be
expressed in undifferentiated MSCs. CYR61 expression
generally seized with any differentiation along different
lineages while WISP3 expression seized in chondrogenic
differentiation, indicating that both polypeptides play
important roles early in commitment or even in uncom-
mitted MSCs [23].
The aim of this study was to establish recombinant expres-
sion of WISP3/CCN6 and to quantify possible chemotac-
tic effects on primary human MSCs in comparison to
CYR61/CCN1. Our results indicate that both CCN-pro-
teins are chemoattractive ligands for human mesenchy-
mal stroma cells before and after osteogenic commitment
and that the effect of WISP3/CCN6 but not CYR61/CCN1
on cell migration of MSCs is mediated by the integrin
receptor ανß5.
Results
Silver staining and western blotting revealed the purity of
the recombinant WISP3-Fc protein (Figure 1). A major
band of the expected size (72 kDa) was visible in these
Silver staining and western blot of recombinant WISP3-Fc Figure 1
Silver staining and western blot of recombinant 
WISP3-Fc. To check the purity of WISP3-Fc SDS gel elec-
trophoresis followed by silver staining and western blotting 
were applied as described in materials and methods. a) west-
ern-blotting analysis, b) silver stained SDS gel. Size of the 
fusion protein is 72 kDa.
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analyses. From two 150 cm2 flasks the purification subse-
quently yielded 100 to 250 μg protein.
Human MSCs used for the chemotaxis assays did not
express markers of differentiated osteoblasts (osteocal-
cin), chondrocytes (collagen type II) or adipocytes (lep-
tin). Immunostaining of MSCs showed that ανß5 integrin
was expressed on the protein level while ανß3 integrin
could scarcely be detected (data not shown). Addition of
dexamethasone, ascorbic acid and ß-glycerophosphate
led to osteogenic differentiation within 21 days, indicated
by the expression of alkaline phosphatase and osteocalcin
(data not shown).
Full length CYR61 and WISP3 induced a dose-dependent
migratory response in human bone marrow derived MSCs
through gelatin-coated chemotaxis filters (Figure 2). An
effect could be observed starting with 1 μg/ml of both
recombinant proteins. With 2 μg/ml migration of 46.3 ±
14.8 cells per well could be observed for CYR61 and 37.0
± 11.0 cells per well for WISP3 in comparison to 16.8 ±
5.8 cells per well for control medium (Figure 2). For MSCs
stimulation with both CCN-proteins was significant at 1
and 2 μg/ml. Single experiments indicated that a further
increase in the concentration of both CCN-proteins to 5
μg/ml and 10 μg/ml result in a gradual decrease of the
migratory response (data not shown). The number of
migrated MSCs compared to 100 ng/ml rhIGF-I was 81%
for 2 μg/ml CYR61 and 74% for 2 μg/ml WISP3. BSA as a
negative control had no stimulatory effect at 2 μg/ml
(26.6 ± 3.5 versus 30.1 ± 1.6 of control medium, M ± SD,
n= 3). For in vitro differentiated MSCs the effect of CYR61
and WISP3 was in a comparable range although the vari-
ation with CYR61 was higher (Figure 3). For dMSCs the
effect of CYR61 was significant at 1 and 2μg/ml and that
of WISP3 at 2 μg/ml.
Since the recombinant proteins both contained the IgG
Fc-tag it was necessary to test whether the Fc-tag itself
influenced cell migration of MSCs or dMSCs. As shown in
Figure 4 we could not observe any relevant stimulation of
cell migration above basal values in concentrations of 0.5,
1 and 2 μg/ml indicating that the migratory effect of the
recombinant protein constructs is specific due to the func-
tion of CYR61 or WISP3.
To rule out the possibility that CYR61 and WISP3 induced
chemokinesis, and not directed cell migration, a checker-
board analysis was performed with the most effective con-
centration of 2 μg/ml. These results (Table 1) clearly
demonstrated that both CCN-proteins stimulated migra-
tion of human MSCs and dMSCs only at a positive con-
centration gradient.
Preincubation of MSCs with the integrin ανß3 antibody
did not have a strong effect on the migratory response to
CYR61 and WISP3 protein. Preincubation with the
integrin  ανß5 antibody did not affect CYR61 induced
migration but completely prevented the effect of WISP3
(Figure 5). In contrast, preincubation with normal mouse
IgG at the same concentration (50 μg/ml) did not influ-
ence the migratory response to both CCN-proteins (Figure
6).
CYR61 and WISP3 stimulate migration of osteogenic differ- entiated MSCs Figure 3
CYR61 and WISP3 stimulate migration of osteogenic 
differentiated MSCs. CYR61/CCN1 and WISP3/CCN6 
stimulate migration of osteogenic differentiated human MSCs 
in a dose dependent manner. Results are presented as abso-
lute numbers of migrated cells from six independent experi-
ments, measured in quadruplicate each (mean ± SD, * p < 
0.05, ** p < 0.01 versus negative control in paired t-test).
CYR61 and WISP3 stimulate migration of human MSCs Figure 2
CYR61 and WISP3 stimulate migration of human 
MSCs. CYR61/CCN1 and WISP3/CCN6 stimulate migration 
of human MSCs in a dose dependent manner. Results are 
presented as absolute numbers of migrated cells from six 
independent experiments, measured in quadruplicate each 
(mean ± SD, * p < 0.05, ** p < 0.01 versus negative control in 
paired t-test).BMC Cell Biology 2007, 8:45 http://www.biomedcentral.com/1471-2121/8/45
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Discussion
A chemotactic effect of CYR61/CCN1 has been previously
described for fibroblasts, alpha smooth muscle cells,
endothelial cells and the murine mesenchymal stem cell
line C3H10T1/2 [18]. We could extend this spectrum to
the stimulation of cell migration in human primary MSCs
before and after osteogenic differentiation. This is of spe-
cial importance since in recent years it has turned out that
locally available, bone-marrow-derived mesenchymal or
osteo-progenitor cells are crucially involved in processes
such as bone growth, remodeling or repair [24]. There-
fore, the mechanisms regulating migratory signals are of
central importance for our understanding of the physiol-
ogy and pathology of bone tissue.
This is the first report that beside full-length CYR61/
CCN1 also full length WISP3/CCN6 acts as a soluble fac-
tor stimulating migration of human bone-marrow-
derived MSCs and dMSCs in a dose-dependent manner.
Moreover, the stimulation could be specified as chemo-
taxis and not chemokinesis and, thus, may contribute to
site-directed cell recruitment in vivo. These results con-
firm the biological activity of both recombinant expressed
proteins. 2 μg/ml of the recombinant CCN-proteins in
Normal mouse IgG does not influence MSC migration to  CYR61 or WISP3 Figure 6
Normal mouse IgG does not influence MSC migra-
tion to CYR61 or WISP3. Preincubation with normal 
mouse IgG does not influence the response of MSCs to 2 μg/
ml CYR61 or 2 μg/ml WISP3. Results are presented as abso-
lute numbers of migrated cells measured in quadruplicate 
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The Fc-tag does not influence migration Figure 4
The Fc-tag does not influence migration. The Fc-tag 
has no influence on migration of human MSCs and osteogenic 
differentiated MSCs up to 2 μg/ml. Results are presented as 
absolute numbers of migrated cells measured in quadrupli-













0.5  g/ml 1  g/ml 2  g/ml neg.
control
0.5  g/ml 1  g/ml 2  g/ml neg.
control
MSC + FC-tag dMSC + FC-tag
Table 1: Checkerboard analysis for migratory effects of CYR61/
CCN1 and WISP3/CCN6.
Well MSC dMSC
negative control 14.3 ± 2.9 16.3 ± 3.7
CCN1/CYR61 lower 55.5 ± 6.5 40.3 ± 4.0
upper&lower 18.8 ± 4.4 15.0 ± 2.9
CCN6/WISP3 lower 43.5 ± 3.2 30.8 ± 3.3
upper&lower 12.0 ± 2.2 13.5 ± 4.2
Checkerboard analysis for migratory effects of CYR61/CCN1 and 
WISP3/CCN6 with human MSCs and in vitro osteogenic differentiated 
MSCs (dMSC). Results are presented as absolute migrated cells (mean 
± SD of one quadruplicate determination). 2 μg/ml CYR61/CCN1 or 
2 μg/ml WISP3/CCN6 were added only to the lower compartment 
(lower) or to both the upper and lower compartment (upper&lower) 
of the chemotaxis chamber to eliminate the concentration gradient.
Integrin ανß5 mediates MSC migration to WISP3 but not to  CYR61 Figure 5
Integrin ανß5 mediates MSC migration to WISP3 
but not to CYR61. Integrin ανß5 mediates MSC migration 
to WISP3/CCN6 but not to CYR61/CCN1-protein. Results 
are presented as absolute numbers of migrated cells from 
three independent experiments measured in quadruplicate 
each (mean ± SD). MSCs were partly preincubated for 1 h 
with 50 μg/ml ανß3 (LM609) or ανß5 (P1F6) antibody (Ab) 
as indicated. CYR61 and WISP3 were used at a concentra-












--- ανß3-Ab ανß5-Ab --- ανß3-Ab ανß5-Ab --- ανß3-Ab ανß5-Ab
CCN1/CYR61 [2 g/ml] CCN6/WISP3  [2 g/ml] neg. control
number of cellsBMC Cell Biology 2007, 8:45 http://www.biomedcentral.com/1471-2121/8/45
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which the Fc-tag accounts for nearly half of the protein
lead to about 70–80% of migrated cells compared to 100
ng/ml rhIGF-I. The concentrations needed for a similar
chemotactic effect of these matricellular proteins were
therefore markedly higher than for other growth factors
but they were comparable to concentrations of CCN-pro-
teins known to elicit cell-biologic responses in previous
studies. The characteristics as matricellular proteins in
tightly binding to heparan sulfate proteoglycans and dis-
tinct integrin receptors as well as the solubility of these
proteins may be related to this point. For chemotactic
processes along far distances proteolytic fragments of
these domain structured proteins might be involved,
which remains to be tested by functional domain bashing
analysis in future experiments. In this context it might be
relevant that IGFBP5 has a direct chemotactic effect on
human MSCs [14]. A similar functional relevance of the
IGFBP-domain of CCN proteins, however, has not been
shown so far.
We have previously shown that in vitro differentiation of
MSCs to the osteogenic phenotype by dexamethasone,
ascorbic acid and ß-glycerophosphate mostly led to a
chemotactic response very similar to that of primary oste-
oblasts [12]. For the CCN-proteins CYR61 and WISP3 we
did not find significant differences between uncommitted
and osteogenic committed MSCs. The aspect of lineage-
specific effects, however, deserves more detailed investiga-
tion [23]. Integrin receptor interaction has previously
been recognized as an important factor with cell-type- and
function-specific influence [25-27]. In agreement with
such an influence, a relevant stimulation of cell migration
in response to CYR61/CCN1 and WISP3/CCN6 could not
be observed with native but with gelatin-coated polycar-
bonate filters which have been used in most previous
studies on migratory effects of CCN-proteins [25,27-30].
Chemotactic effects of CYR61 are known to be mediated
by integrin ανß3 in endothelial cells and by integrin ανß5
in fibroblasts [25,31]. Our results indicate that in MSCs
ανß3 integrin does not strongly contribute to the trans-
mission of migratory signals by CYR61 and WISP3-pro-
teins. Most interestingly, we found that ανß5 integrin is
not involved in MSC migration to CYR61 while the chem-
otactic effect of WISP3 was completely dependent on this
integrin receptor. In agreement with these results immu-
nostaining indicated that ανß5 integrin was expressed on
MSCs while ανß3 integrin could scarcely been detected.
These results represent the first data on the role of integrin
receptors in WISP3 induced cell migration and indicate
ligand-specific involvement of integrin receptors within
CCN-proteins. A possible role of other integrin receptors
like α6ß1 or heparan sulfate proteoglycans for CYR61 and
WISP3 mediated stimulation of MSC-migration has to be
addressed in future studies. Moreover, the relationship to
chemoattractive effects of certain chemokines and other
growth factors on MSCs is largely unknown so far.
Conclusion
Our in vitro data show that recombinant CYR61 and
WISP3-proteins both stimulate directed migration of
human MSCs and committed osteogenic precursor cells.
The chemotactic activity of these two members of the
CCN-protein family differently involves integrin ανß5 in
MSCs, indicating a further level of regulation. This may be
relevant for MSC recruitment and migration in the context
of skeletal development and repair.
Methods
Cell Culture
With informed consent, following the guidelines from the
ethics committee of the University of Ulm, bone marrow
samples from eight donors (age 20 to 39 years) were
plated and cultured in Dulbecco's modified eagle medium
(DMEM; Biochrom, Germany) containing 10% FCS as
described previously [12]. All cell culture experiments
were performed in the first four cell passages. The tech-
nique of cell isolation and cultivation preserves the
multipotency phenotype, indicated by absent or very low
expression of alkaline phosphatase or osteocalcin, and the
potential to differentiate to the chondrogenic, osteogenic
and adipogenic phenotype [32]. The cell populations
were characterized by positive staining with anti-CD9,
CD54, CD166, and STRO-1 as cell surface markers known
to be expressed by human MSCs [32]. Immunostaining
for integrin ανß3 and integrin ανß5 was performed with
receptor specific antibodies (LM609 for ανß3 and P1F6
for  ανß5, both Chemicon International, United King-
dom) using hemalaun as nuclear counterstain to improve
visualization of the cells. SF-21 insect cells were cultured
in BacPAK complete medium (Clontech, Saint-Germain-
en-Laye France) at 27°C. SF-21 cells were split and
medium was changed once a week.
Osteogenic differentiation of MSCs and analysis of gene 
expression
Medium for osteogenic differentiation, containing DMEM
with 0.1 μM dexamethasone, 10 mM ß-glycerophosphate
and 50 μg/ml ascorbic acid, was changed every third day
as described [12]. Osteogenic differentiation was demon-
strated at day 21 by RT-PCR gene expression analysis of
the marker genes alkaline phosphatase and osteocalcin as
described elsewhere [16].
Cloning for WISP3 expression
The open reading frame for WISP3 was amplified from a
plasmid (IMAGp956O19142) obtained from the
Resource Center Primary Database (Berlin, Germany).
Primers corresponding to the translational start site
(including the KOZAK Sequence of the WISP3 cDNABMC Cell Biology 2007, 8:45 http://www.biomedcentral.com/1471-2121/8/45
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sequence) and the stop site (the primer lacked the stop
codon) contained restriction sites at the 5'end (XhoI and
EcoRI in the forward and reverse primer, respectively). The
PCR product was subcloned into a TA-TOPO vector (pCR
2.1, Invitrogen, Karlsruhe, Germany). The insert was pre-
pared by double restriction (EcoRI/XhoI) and cloned into
the transfer vector pBakPak 8 (Clontech, Saint-Germain-
en-Laye France). The Fc-domain of human IgG was ampli-
fied from a PC3 expression vector (kindly provided by Dr.
Pascal Schneider, University of Lausanne, Switzerland) by
PCR using primers with EcoRI and NotI restriction sites,
respectively and was subcloned 3' to the open reading
frame of WISP3 to generate the final recombinant vector.
Transfection of insect cells and expression of full-length 
CYR61 and WISP3 proteins
SF-21 caterpillar (lepidopteran) derived cells were used to
express recombinant WISP3-protein (rWISP3). The
recombinant vector was mixed with linearized DNA that
contained a modified Autographa californica multiple
nucleopolyhedrovirus (AcMNPV) genome. SF-21 cells
were transfected with bacfectin according to the supplier's
information in wells of 6-well plates. After 7 days at 27°C
in serum containing medium the supernatant (passage 1)
was used to infect SF-21 cells in 25 cm2 flasks using serum-
free culture conditions. After 7 days the supernatants (pas-
sage 2) were checked for protein expression and further
amplified one round using 75 cm2 flasks to generate the
final stock (passage 3) which was stored in aliquots at -
80°C for further purifications of the protein. To purify the
rWISP3-protein, protein G sepharose columns (1 ml col-
umns, GE Healthcare, Freiburg, Germany) were equili-
brated with pH 7 buffered PBS, the supernatant was
applied (volumes between 45–90 ml) at a flow rate of 1
ml per min. Columns were washed with 10 column vol-
umes of PBS and the protein eluted with elution buffer
(0.1 M glycine, pH 2.2). Directly thereafter eluted frac-
tions were neutralized using 3 M Tris/HCL pH 8. The yield
was determined by a Bradford protein assay. The purity of
the protein was finally checked by SDS gel electrophoresis
followed by silver staining and western blotting. CYR61
was purified as described previously [17].
The purification of the Fc-tag was done in parallel using
similar procedures. The Fc-domain of human IgG was
amplified from a PC3 expression vector (kindly provided
by Dr. Pascal Schneider, University of Lausanne, Switzer-
land) by PCR using primers containing EcoRI and NotI
restriction sites and subcloned into the transfer vector
pBakPak 8 (Clontech, Saint-Germain-en-Laye France).
Further virus amplification and protein purification was
done essentially as described above for the CCN-proteins.
Chemotaxis Assay
Cell migration was analyzed by a modified Boyden cham-
ber assay, using a 48-well micro-chemotaxis chamber
(NeuroProbe Inc., Baltimore, MD, USA) and polycar-
bonate filters with 8 μm pores (Whatman Biometra, Gött-
ingen, Germany), as described previously [14]. For the
present study the filters were coated with gelatin. The cells
were trypsinized, counted and used for RT-PCR as well as
for the chemotaxis assay. The lower wells were filled with
0.5, 1 and 2 μg/ml of the CCN-proteins in DMEM and
covered by the chemotaxis filter. The protein concentra-
tion was routinely tested using a Bradford assay. The
upper wells were filled with 1 × 104 cells in 50 μL DMEM.
After 4 h incubation, the filter was carefully removed and
non-migrated cells on the upper side eliminated by rins-
ing with cold PBS and scraping over a rubber wiper. The
migrated cells in the solution on the lower side of the filter
were fixed with 4% formaldehyde and stained with
"Giemsa". Control wells only containing DMEM in the
bottom well were applied for each experiment. Condi-
tioned medium of human osteoblast cultures was used as
a positive control, analogous to the use of conditioned
medium from fetal cultures for fibroblast chemotaxis
[33]. In control wells, containing only DMEM, the
number of migrated cells was about 10 to 30 cells, while
the amount of migrated cells in the wells with condi-
tioned medium was greater than 1000 cells. Additional
control experiments were performed with the Fc-tag in
concentrations of 0.5, 1 and 2 μg/ml using MSCs and
dMSCs from two different donors. As a negative control
the effect of 2 μg/ml BSA (Sigma, Deisenhofen, Germany)
was tested with MSCs from three different donors. In a
positive control experiment the effect of 100 ng/ml rhIGF-
I (Pepro Tech Inc, Rocky Hill, NJ, USA) on MSC-migration
was tested in parallel to CYR61 and WISP3. The number
of migrated cells in control and stimulated wells was
counted at 100-x magnification. A Zigmond-Hirsch
checkerboard analysis was performed in triplicate to dis-
tinguish between concentration-dependent cell migration
(chemotaxis) and random migration (chemokinesis).
Therefore, the effect of elimination of the concentration
gradient by adding the test substances (2 μg/ml each) to
the upper and lower compartments of the chemotaxis
chamber [34] was tested in parallel. Finally, the involve-
ment of integrin receptors ανß3 and ανß5 was studied by
preincubation of MSCs with specific antibodies (LM609
for  ανß3 and P1F6 for ανß5, Chemicon International,
United Kingdom) for 1 h at a concentration of 50 μg/ml
each. Preincubation with 50 μg/ml normal mouse IgG
(Sigma, Deisenhofen, Germany) was used as an unspe-
cific control.BMC Cell Biology 2007, 8:45 http://www.biomedcentral.com/1471-2121/8/45
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SDS gel electrophoresis, silver staining and western 
blotting
SDS gel electrophoresis, silver staining and western blot-
ting essentially were performed as described previously
[17]. The WISP3-protein was detected using a polyclonal
antiserum raised in rabbits against the full-length human
CYR61-Fc fusion protein, which detects the Fc-tag. Con-
trols using the secondary antibody only were negative.
Statistics
The chemotaxis experiments on dose-dependent effects of
CYR61 and WISP3 were performed in quadruplicate, for
MSCs and osteogenic differentiated MSCs (dMSCs) in
independent experiments with cells from six different
donors, and the mean value for each donor was used for
statistical analysis. Experiments with integrin-blocking
antibodies were done in quadruplicate determinations
with cells from three different donors each. Results are
presented as mean ± standard deviation. The significance
of differences in chemotactic responses compared to the
negative control was determined using Student's t-test for
paired samples. A value of P <0.05 was considered statis-
tically significant.
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